Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints.

Por Cliby, W A, Roberts, C J, Cimprich, K A, Stringer, C M, Lamb, J R, Schreiber, S L, Friend, S H
Publicado em 1998

Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas.

Por Persons, D. L., Hartmann, L. C., Herath, J. F., Borell, T. J., Cliby, W. A., Keeney, G. L., Jenkins, R. B.
Publicado em 1993

Intake of coffee, caffeine and other methylxanthines and risk of Type I vs Type II endometrial cancer

Por Uccella, S, Mariani, A, Wang, A H, Vierkant, R A, Cliby, W A, Robien, K, Anderson, K E, Cerhan, J R
Publicado em 2013

Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines

Por Peasland, A, Wang, L-Z, Rowling, E, Kyle, S, Chen, T, Hopkins, A, Cliby, W A, Sarkaria, J, Beale, G, Edmondson, R J, Curtin, N J
Publicado em 2011